Associated Papers
SLCO1B1 Exome Sequencing and Statin Treatment Response in 64,000 UK Biobank Patients.
Türkmen D et al.
International Journal of Molecular Sciences, 2024
38674010 (PubMed )
Supplement: ijms-25-04426-s001.zip › Supplementary_Tables.SLCO1B1_exomes_2024.04.17.xlsx › Table_S7
A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance.
Bigossi M et al.
European Heart Journal. Cardiovascular Pharmacotherapy, 2023
An Unnecessary Pain: Using Pharmacogenetics for Statin-related Skeletal Muscle Toxicity.
Alzghari SK
Cureus, 2018
Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition.
Zhou F et al.
Advanced Drug Delivery Reviews, 2017
Frequencies of single-nucleotide polymorphisms and haplotypes of the SLCO1B1 gene in selected populations of the western balkans.
Grapci AD et al.
Balkan Journal of Medical Genetics : Bjmg, 2015
Single nucleotide polymorphism markers for low-dose aspirin-associated peptic ulcer and ulcer bleeding.
Shiotani A et al.
Journal of Gastroenterology and Hepatology, 2014
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.
Donnelly LA et al.
Clinical Pharmacology and Therapeutics, 2011
Hepatic OATP1B transporters and nuclear receptors PXR and CAR: interplay, regulation of drug disposition genes, and single nucleotide polymorphisms.
Meyer zu Schwabedissen HE et al.
Molecular Pharmaceutics, 0
Association between single nucleotide polymorphism SLCO1B1 gene and simvastatin pleiotropic effects measured through flow-mediated dilation endothelial function parameters.
Andrianto et al.
Therapeutic Advances in Cardiovascular Disease, 0
Select a paper to view details